StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com

Natrics Corp. 8-K: Sheng YinHao Takes Control, Gets 25 Million Shares

Sheng YinHao acquired 54.59% of Natics Corp. for $500,000 and was issued 25 million shares as a retention bonus, making him 91.82% owner, per an 8-K.

What happened

Natrics Corp., a Wyoming-incorporated company whose principal office is listed in Shenzhen, China, reported a change in control in a Form 8-K filed Nov. 13, 2026. The filing says Sheng YinHao acquired 3,000,000 shares, about 54.59% of the outstanding common stock, from Guy Pirotsky for $500,000 in cash under a stock purchase agreement effective Oct. 27, 2026.

Separately, the filing says the company issued Sheng YinHao 25,000,000 shares of common stock in November 2026 as a retention bonus, valued at $0.60 per share.

The filing also states that on Dec. 31, 2025, Pirotsky resigned as President, Secretary, Treasurer, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and a director; Aleksandre Machitidze and Giorgi Gavaketashvili resigned as directors; and Sheng was appointed sole director, President, Chief Executive Officer, Treasurer and Secretary.

After the purchase and the share issuance, Sheng beneficially owns 28,000,000 shares, or 91.82% of the 30,495,300 shares outstanding as of the filing date, according to the company's beneficial ownership table.

The stock closed at $0.70 on the event date, down 6.67% from the prior close of $0.75, according to the price data.

About the company

Natrics Corp. is listed on the filing cover under the category Services-Computer Processing & Data Preparation and is registered under Section 12(g) of the Securities Exchange Act, with the ticker NTCS. The filing does not identify an exchange under that ticker; the cover states "N/A" in the exchange column.

The filing does not describe the company's current operations or revenue in any further detail.

The filing

The 8-K carries four items: 3.02 (unregistered sales of equity securities), 5.01 (changes in control), 5.02 (departure and appointment of officers and directors) and 9.01 (financial statements and exhibits).

The company says the 25,000,000-share issuance was made without registration under the Securities Act in reliance on Section 4(a)(2) and Regulation D, based on the sale to a single accredited investor, with no general solicitation or advertising, and with the buyer acquiring the shares for his own account rather than for distribution.

The filing attaches the stock purchase agreement between Sheng and Pirotsky as Exhibit 10.1. It also includes Sheng's background, describing him as 38 and a founder or executive at several China-based companies in health technology, business services, catering and trading.

What this means

A Form 8-K is the current-report form public companies file to disclose material events between regular quarterly and annual reports. The item numbers tell readers what kind of event is being reported. Item 5.01 is the one used to disclose a change of control — here, a private stock purchase, not a tender offer or merger, in which the buyer paid the seller directly for his shares. Item 3.02 covers sales of stock that were not registered with the SEC. Item 5.02 covers changes in directors and executive officers.

The mechanics of the ownership change matter because of dilution. Sheng's 3,000,000-share purchase gave him voting control at roughly 54.59%. The separate 25,000,000-share retention bonus, valued at $0.60 per share, was issued by the company itself rather than bought from an existing holder. That increased the total share count and lifted Sheng's stake to 91.82%, reducing every other holder's percentage of the company. The filing does not state why the company chose to pay a retention bonus in stock rather than cash, or why the 25 million figure was chosen.

The filing does not explain why Pirotsky sold control or why the officer and director resignations are dated Dec. 31, 2025 — roughly ten months before the change of control was reported as effective. It also does not state what the company intends to do under new management. The $0.60 valuation used for the bonus shares compares with a $0.70 closing price on the event date, per the price data.

A note of caution on timing: the filing's date of earliest event is listed as Nov. 13, 2026, with Oct. 27, 2026 in parentheses, and the resignations are dated Dec. 31, 2025, which precedes both. Readers should treat the sequence as the filing presents it.

Sources

Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.